Lyrica
Product Images NDC 0071-1020

Product Visual Gallery

This gallery contains 34 technical images submitted to the FDA as part of the official labeling for Lyrica (NDC 0071-1020). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Parke-davis Div Of Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cockcroft And Gault Equation (Lyrica 01)

This is a formula to calculate creatinine clearance for adults. It involves multiplying the weight of the patient (in kilograms) by the serum creatinine level (in milligrams per deciliter) and then dividing by a constant of 72. In female patients, the constant is multiplied by 0.385.*

FDA Label Image

Chemical Structure (Lyrica 02)

FDA Label Image

Figure 1 (Lyrica 03)

FDA Label Image

Figure 2 (Lyrica 04)

FDA Label Image

Figure 3 (Lyrica 05)

This text is not available as it contains unclear and unreadable characters.*

FDA Label Image

Figure 4 (Lyrica 06)

This appears to be a table displaying the percentage of patients who improved while taking different doses of Pregabalin compared to a placebo group. There are three groups listed: Pregabalin 200 mg taken three times a day, Pregabalin 100mg taken twice a day, and a group that received a placebo. However, the table is not fully readable as there are some characters that are not English and parts of the text are garbled, making it difficult to understand the full context.*

FDA Label Image

Figure 5 (Lyrica 07)

This text appears to be a report on the percentage of patients who showed improvement in pain after taking Pregatalin 100 and Progabalin 80. The frequency of intake is mentioned for both medicines, with Pregatalin taken "mothrestimes aday" and Progabalin taken "mathrestimesa day". The word "Plac" appears on the third line, but its meaning is not clear. The last line shows a chart with the percentages of improvement in pain from baseline, represented by numbers ranging from 0 to 20. However, the characters are too distorted to interpret the values accurately. Overall, this text contains some medical terms and abbreviations but lacks context and organization, making it difficult to understand without further information.*

FDA Label Image

Figure 6 (Lyrica 08)

FDA Label Image

Figure 7 (Lyrica 09)

FDA Label Image

Figure 8 (Lyrica 10)

The text appears to show a table with two columns and several rows. The first column appears to show the responder rate percentage, while the second column could contain names of treatments or substances. The numbers in the first column range from 40.6% to 226%. The second column includes the words "Placebo", "2.5 mg/kg/day", and "10 mg/kg/day" alongside some number values. Unfortunately, the context of the table is not clear.*

FDA Label Image

Figure 9 (Lyrica 11)

FDA Label Image

Figure 10 (Lyrica 12)

FDA Label Image

Figure 11 (Lyrica 13)

This is a table showing the percentage improvement of subjects in response to Pregabalin from baseline to week 12 using the BOCF criteria. The percentages range from 50 to 100, with the highest percentage improvement being 100%.*

FDA Label Image

Logo (Lyrica 14)

FDA Label Image

Lyrica 14a

This is a statement indicating that a particular product is distributed by Parke-Davis which is a division of Pfizer Inc. The products involved and the context are not provided.*

FDA Label Image

Lyrica 14b

This is a description of a company called Parke-Davis, which is a division of Pfizer Inc, located in NY, NY 10017. The text indicates that Parke-Davis distributes something, although without additional information it is unclear what is being distributed.*

FDA Label Image

Principal Display Panel (25 mg Capsule Bottle Label)

This is a description of Lyrica medication in capsule form. The medication contains 25 mg pregabalin and is stored at 25°C (77°F). Excursions are permitted to 15-30°C (59-86°F). The medication is distributed by Frke Dags and is enclosed in a child-resistant container. The accompanying prescribing information must be consulted before use. The medication comes in a bottle of 90 capsules and is available only with a prescription. The GTIN and NDC numbers are not for commercial inventory purposes. Made in Singapore.*

FDA Label Image

Principal Display Panel (50 mg Capsule Blister Pack)

Lyrica® is a medication manufactured by Pfizer, Inc. that contains the active ingredient pregabalin. It comes in capsule form, with a strength of 50 mg. The drug is prescribed for the treatment of neuropathic pain, fibromyalgia, seizures, and anxiety disorders. The text also contains information related to the drug's manufacturer, Parke-Davis, and includes a medication guide with dosage instructions.*

FDA Label Image

Principal Display Panel (50 mg Capsule Blister Pack Carton)

Lyrica (pregabalin) capsules are available in unit dose of 100 capsules for in-institution use only. Each capsule contains 50 mg pregabalin. The drug should always be dispensed with the medication guide. It should be stored at 25°C (77°F), however, excursions are permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature]. Further information such as dosage and use can be obtained from accompanying prescribing information. The drug is distributed by Parke-Davis, a division of Pfizer Inc, NY, NY 10017.*

FDA Label Image

Principal Display Panel (50 mg Capsule Bottle Label)

Store the medication Lyrica (pregabalin) capsules in a tight and chill-resistant container at a temperature between 15-30°C (50-86°F), with permission to store at 25°C (77°F) as per USP Controlled Room Temperature. The prescribing information should be consulted for dosage and use instructions. The medicine is distributed by Parke-Davis Division of Pizr Inc., NY, NY, and comes in a pack of 90 capsules. Always dispense the medication with the accompanying medication guide. No non-English characters were detected.*

FDA Label Image

Principal Display Panel (75 mg Capsule Blister Pack)

Lyrica (pregabalin) 75mg capsule. Lot number and expiration date not available. Manufactured by Parke-Davis, division of Pfizer Inc. NY. NY 10017. Lyrica is a medication used to treat pain caused by nerve damage due to diabetes, shingles or injury. It may also be used to treat seizures and anxiety disorders.*

FDA Label Image

Principal Display Panel (75 mg Capsule Blister Pack Carton)

This is a description of a medication called Lyrica, which is available in capsules of 75mg. It is for in-institution use only and comes in a pack of 100 capsules. The medication guide is always dispensed with the capsules. The capsules need to be stored between 15-30°C (59-86°F). Further dosage and use information is provided in the prescribing information. The distributor of the medication is mentioned as Parke-Davis.*

FDA Label Image

Principal Display Panel (75 mg Capsule Bottle Label)

This text describes the storage instructions and dosage information for Lyrica capsules containing pregabalin. It provides the NDC and GTIN identification codes for the product, and emphasizes the need to dispense the medication with its accompanying prescribing information and medication guide. The medication should be stored at 25°C (77°F) and can be stored temporarily at temperatures between 15-30°C (59-86°F). The capsules should be dispensed in tight, child-resistant containers. The product is distributed by Parke-Davis, a division of Pfizer Inc, and is made in Singapore.*

FDA Label Image

Principal Display Panel (100 mg Capsule Blister Pack)

Lyrica is a medication containing pregabalin, available in capsules of 100 mg. The manufacturer is a division of Pfizer, located in New York City.*

FDA Label Image

Principal Display Panel (100 mg Capsule Blister Pack Carton)

Lyrica® Ev (pregabalin) capsules, each containing 100mg of pregabalin. This medication is for in-institution use only and comes in a package of 100 capsules. As per the instructions, this medication should only be dispensed with a medication guide. The storage temperature is between 15-30°C (59-86°F). For more information about the drug, refer to the prescribing information.*

FDA Label Image

Principal Display Panel (100 mg Capsule Bottle Label)

This text provides information about the storage, handling, and dosage of pregabalin capsules. The suggested storage temperature is 25°C (T7°F) with permitted excursions to 15-30°C (50-86°F). The capsules should be dispensed in child-resistant containers and dispensed with the accompanying medication guide. Each capsule contains 100mg of pregabalin. The distributing company is Parke-Davis, a division of Pfizer Inc. This medication is a prescription-only drug provided in 90 capsules.*

FDA Label Image

Principal Display Panel (150 mg Capsule Blister Pack)

Lyrica (pregabalin) is a medication available in capsule form, manufactured by Parke Davis, a division of Pfizer Inc. It comes in a 150mg dosage strength and is indicated for the treatment of nerve pain, anxiety, and other conditions. The lot number and expiration date are also provided on the packaging.*

FDA Label Image

Principal Display Panel (150 mg Capsule Blister Pack Carton)

This text is a description of medication labeled as Lyrica (pregabalin) capsules. The medication is available in 100 Unit Dose capsules for in-institutional use only. The medication guide should always be dispensed with it. The dosage and use should be consulted from the accompanying prescribing information. Each capsule contains 150mg pregabalin which is distributed by Parke-Davis Division of Pfizer Inc, located in NY. The medication should be stored at a temperature of 25°C (77°F) with allowed excursions of 15-30°C (59-86°F). The GTIN code for the product is 0030071016414.*

FDA Label Image

Principal Display Panel (150 mg Capsule Bottle Label)

This is a prescription drug called Lyrica (pregabalin) that comes in capsules of 150mg and should be stored between 15-30°C (59-86°F) with an excursion permitted to 25°C (77°F). The prescribing information needs to be consulted before use. It is distributed by Parke-Davis division of Pfizer in the US and comes in child-resistant containers. It is made in Singapore and comes in a pack of 90 capsules. No further information is available.*

FDA Label Image

Principal Display Panel (200 mg Capsule Bottle Label)

This is a medication called Pregabalin contained in 90 capsules of 200mg each. It should be stored at a temperature between 15-30°C (69-86°F) and in child-resistant containers. The accompanying prescribing information should be consulted when determining dosage and use. This medication is distributed by Parke-Davis, located at 10017 L bl in New York City, and is made in Singapore.*

FDA Label Image

Principal Display Panel (225 mg Capsule Bottle Label)

Store the medication at a temperature of 25°C (77°F) with permissible excursions between 15-30°C (59-86°F) as per USP Controlled Room guidelines. Detailed information on dosage and usage is available with accompanying prescribing information. Each capsule of this medication contains 225mg of pregabalin. This product is distributed by Parke-Davison of Pfizer Inc., located in New York, NY 10017 and it is manufactured in Singapore. This is a prescription medication with 90 capsules to be dispensed in child-resistant containers.*

FDA Label Image

Principal Display Panel (300 mg Capsule Bottle Label)

Store the medication at a temperature between 15-30°C (59-86°F), with excursions allowed up to 25°C (77°F), as instructed by USP Controlled Room Temperature. Dispense the capsules in tight, child-resistant containers. Each capsule contains 300mg Pregabalin. To learn about the dosage and usage, please refer to the accompanying prescribing information. The medication is distributed by Parke-Davis Division of Pfizer Inc., New York, NY 10017 and is made in Singapore. The product is available in 90 capsule packages and only available with a prescription. If applicable, always dispense with a medication guide. GTIN is available.*

FDA Label Image

Principal Display Panel (20 mg Bottle Label)

FDA Label Image

Principal Display Panel (20 mg Bottle Carton)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.